We are live on ! Find out more
MG

Marex Group Portfolio holdings

AUM $23.6B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+50.25%
1 Year Est. Return
+57.16%
3 Year Est. Return
+254.23%
5 Year Est. Return
10 Year Est. Return
AUM
$23.6B
AUM Growth
+$7.75B
Cap. Flow
+$1.27B
Cap. Flow %
5.38%
Top 10 Hldgs %
32.82%
Holding
1,394
New
387
Increased
323
Reduced
330
Closed
277

Top Buys

Rank Stock Value
1
AAOI icon
Applied Optoelectronics
AAOI
+$413M
2
NOW icon
ServiceNow
NOW
+$374M
3
SPCX
SpaceX
SPCX
+$368M
4
AXTI icon
AXT Inc
AXTI
+$320M
5
ASTS icon
AST SpaceMobile
ASTS
+$312M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$364M
2
LITE icon
Lumentum
LITE
+$290M
3
MSTR icon
Strategy Inc
MSTR
+$282M
4
MA icon
Mastercard
MA
+$211M
5
BKNG icon
Booking.com
BKNG
+$183M

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.34%
2 Technology 28.9%
3 Industrials 5.15%
4 Financials 4.71%
5 Healthcare 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCLH icon
926
Norwegian Cruise Line
NCLH
$7.15B
$252K ﹤0.01%
11,956
-10,483
-47% -$196K
RMD icon
927
ResMed
RMD
$32.9B
$251K ﹤0.01%
+1,287
New +$267K
SYM icon
928
Symbotic
SYM
$5.58B
$250K ﹤0.01%
+5,564
New +$284K
FSCO
929
FS Credit Opportunities Corp
FSCO
$1.07B
$250K ﹤0.01%
50,108
+12,507
+33% +$62.8K
LNC icon
930
Lincoln National
LNC
$8.71B
$250K ﹤0.01%
+7,064
New +$254K
OSS icon
931
One Stop Systems
OSS
$249M
$249K ﹤0.01%
+13,700
New +$191K
RCKT icon
932
Rocket Pharmaceuticals
RCKT
$424M
$248K ﹤0.01%
72,500
COHU icon
933
Cohu
COHU
$2.4B
$247K ﹤0.01%
+3,344
New +$167K
GLO
934
Clough Global Opportunities Fund
GLO
$242M
$247K ﹤0.01%
40,359
CPRT icon
935
Copart
CPRT
$31.2B
$247K ﹤0.01%
+8,753
New +$283K
SPUU icon
936
Direxion Daily S&P 500 Bull 2X ETF
SPUU
$290M
$247K ﹤0.01%
+1,144
New +$234K
VSAT icon
937
Viasat
VSAT
$10.4B
$245K ﹤0.01%
+2,732
New +$181K
PATH icon
938
UiPath
PATH
$7.87B
$245K ﹤0.01%
22,498
-3,058
-12% -$32.6K
EXC icon
939
Exelon
EXC
$45B
$244K ﹤0.01%
+5,225
New +$242K
CMS icon
940
CMS Energy
CMS
$21.5B
$243K ﹤0.01%
+3,182
New +$239K
REGN icon
941
Regeneron Pharmaceuticals
REGN
$85.2B
$243K ﹤0.01%
389
-1,350
-78% -$919K
FLUT icon
942
Flutter Entertainment
FLUT
$17.4B
$242K ﹤0.01%
2,373
-816
-26% -$84.1K
CIBR icon
943
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.2B
$242K ﹤0.01%
2,695
-1,954
-42% -$150K
URI icon
944
United Rentals
URI
$62.9B
$241K ﹤0.01%
213
-1,053
-83% -$1M
BEAM icon
945
Beam Therapeutics
BEAM
$3.06B
$241K ﹤0.01%
+7,021
New +$212K
RL icon
946
Ralph Lauren
RL
$20.9B
$240K ﹤0.01%
+598
New +$223K
CLS icon
947
Celestica
CLS
$39.4B
$240K ﹤0.01%
658
-1,484
-69% -$557K
VNQ icon
948
Vanguard Real Estate ETF
VNQ
$38.1B
$240K ﹤0.01%
2,488
-1,998
-45% -$191K
COGT icon
949
Cogent Biosciences
COGT
$6.03B
$239K ﹤0.01%
+6,176
New +$216K
SWKS icon
950
Skyworks Solutions
SWKS
$11.1B
$238K ﹤0.01%
3,504
-3,954
-53% -$269K

Similar funds

Marex Group's Q2 2026 Portfolio in Review

As of Q2 2026, Marex Group held 1,394 positions worth $23.6B, up 49% from $15.8B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marex Group deployed $1.27B of net new capital in Q2 2026, opening 387 new positions and adding to 323 existing holdings. Its largest new stake was SpaceX: 2,163,897 shares worth $370M.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, up from 48% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Sandisk, an estimated $364M trimmed.

  • Marex Group's largest Q2 2026 buy was SpaceX: 2,163,897 shares worth $370M.
  • Marex Group added most to Applied Optoelectronics in Q2 2026, an estimated $413M increase.
  • Marex Group's biggest Q2 2026 reduction was Sandisk, cutting an estimated $364M.
  • Marex Group fully exited Blackrock in Q2 2026, selling an estimated $77.5M.
  • Marex Group's ten largest holdings make up 33% of its $23.6B portfolio in Q2 2026.
  • Marex Group opened 387 new positions and closed 277 in Q2 2026.
  • Marex Group's portfolio value rose 49% quarter-over-quarter to $23.6B.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.